socalTECH
NOVEMBER 8, 2019
Pasadena-based robot developer Miso Robotics is turning towards equity crowdfunding for its next fundraise, the company said this week. Miso--known for its kitchen assistant robot, Flippy--says it has started opening up reservations for a new equity crowdfunding round. The funding is also being supported by Wavemaker Labs, the "startup studio" arm of investment firm Wavemaker Ventures.
L.A. Business Journal
NOVEMBER 8, 2019
Southern California Edison announces start date for AECOM-led project to decommission the San Onofre nuclear power plant.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
NOVEMBER 8, 2019
Los Angeles-based expense and invoice management software developer Chrome River has signed on a big new customer, enterprise software developer TIBCO Software. According to Chrome River, TIBCO will deploy its Chrome River EXPENSE software across its organization, replace an existing expense management solution. Financial impact of the customer win was not announced.
SoCal Tech Calendar
NOVEMBER 8, 2019
Thursday, November 14, 2019 -- Masters of Game Design Speaker Series w/ Voldi Way. Join WayForward's "Tyrannical Overlord" Voldi Way (Shantae series, Adventure Time, Duck Tales Remastered, TMNT, Aliens Infestation, Mighty Switch Force!, A Boy and his Blob and many, many more!) in a chat with NYFA's Scott Rogers (God of War, author of Level Up! The Guide to Great Game Design) as they discuss Voldi's career running one of the longest lasting independent game studios.
Advertiser: Aggregage
Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.
socalTECH
NOVEMBER 8, 2019
San Diego-based Teradata , a provider of cloud-based data analytics software for the business market, has swapped its CEO, saying Thursday afternoon that its former CEO, Oliver Ratzesberger, is no longer its President and CEO, and also has resigned from Teradata's board. The reasons for the abrupt departure of Ratzesberger were not given. According to Teradata, it has named Victor Lund, currently executive Chairman of Teradata's board of diretors as Interim President and Chief Executive Officer.
Startup Professionals Musings
NOVEMBER 8, 2019
In my role as a mentor to entrepreneurs and an angel investor, I find that too many are stuck in this myth that a good pitch, and good marketing content, should consist of more product features, and more hype on customer benefits. Naturally, these are important, but real winning content has to start with a story that excites people’s imagination, and pulls them in emotionally.
Southern California Tech Central brings together the best content for technical professionals in Southern California from the widest variety of industry thought leaders.
SoCal Tech Calendar
NOVEMBER 8, 2019
Thursday, November 14, 2019 --.
L.A. Business Journal
NOVEMBER 8, 2019
Army Corps of Engineers awards Tetra Tech a contract worth up to $40 million.
L.A. Business Journal
NOVEMBER 8, 2019
Los Angeles’ electric vehicle companies keep plugging along despite setbacks.
Xconomy
NOVEMBER 8, 2019
During the state of the union address this year, President Trump pledged to end HIV transmission within the next decade. A key part of that plan are HIV prevention drug made by Gilead Sciences. Those drugs have now become the center of a patent dispute between the Foster City, CA, drug maker and the federal government. This week, the government filed a patent infringement suit in federal court against Gilead (NASDAQ: GILD ).
Xconomy
NOVEMBER 8, 2019
Danish diabetes giant Novo Nordisk took another step this week in its efforts to establish a presence in nonalcoholic steatohepatitis, or NASH, a metabolic disorder closely related to diabetes that is anticipated to become the leading cause of liver transplants in the US in coming years. The company Thursday announced it had inked a deal with Ube Industries, a Japanese industrial conglomerate, for worldwide rights to UD-014, a preclinical small molecule drug that it plans to advance as a potenti
Expert insights. Personalized for you.
113 
Let's personalize your content